1. A. H. CFA. Enterprise Value (EV), Investopedia, 18-Nov-2003. [Online]. Available: https://www.investopedia.com/terms/e/enterprisevalue.asp. Accessed 23 Jan 2018.
2. Awards & Recognition, Celgene, 26 Apr 2016. [Online]. Available: http://www.celgene.com/about/awards-recognition/. Accessed 16 Jan 2018.
3. Bilello, J. A. (2005). The agony and ecstasy of ‘OMIC’ technologies in drug development. Current Molecular Medicine, 5(1), 39–52.
4. Biotech blastoff: Synageva up 112% on $8B Alexion deal, USA TODAY. [Online]. Available: https://www.usatoday.com/story/money/business/2015/05/06/alexion-synageva/70909976/. Accessed 26 Jan 2018.
5. Campbell, T. Is this Gilead sciences’ biggest mistake in 2016?, The Motley Fool, 16-Dec-2016. [Online]. Available: https://www.fool.com/investing/2016/12/16/is-this-gilead-sciences-biggest-mistake-in-2016.aspx. Accessed 26 Jan 2018.